| 2024/08/30 08:20:52 | |
|---|---|
| Price | |
| 2.075 EUR | |
| Difference | 0.00% (0.00) |
General attributes
| ISIN | FR0010331421 |
| Symbol | IPH |
| Exchange | Munich |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 169 EUR |
| Benchmark | CAC 40 INDEX |
Market data
| Bid (Bid size) | - |
| Ask (Ask size) | - |
| Open | 2.075 EUR |
| High | 2.075 EUR |
| Low | 2.075 EUR |
| Close (prev. day) | 2.075 EUR |
| VWAP | 2.15 EUR |
| Volume (pcs) | 0 |
| Trading volume | 0.00 |
| Number of trades | 1 |
| Last size | 0 |
Futures and Options
| Related Futures | 0 |
| Related Options | - |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2024/08/12 |
|
Global Equity Ratings |
|
| 2024/07/03 |
|
Global Strategy 3Q 2024 |
|
| 2024/06/21 |
|
Global Equity Ratings |
|
| 2024/06/14 |
|
Global Equity Ratings |
|
| 2024/04/26 |
|
Global Equity Ratings |
|
| 2024/08/30 08:20:52 | |
|---|---|
| Price | |
| 2.075 EUR | |
| Difference | 0.00% (0.00) |
General attributes
| ISIN | FR0010331421 |
| Symbol | IPH |
| Exchange | Munich |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 169 EUR |
| Benchmark | CAC 40 INDEX |
Market data
| Bid (Bid size) | - |
| Ask (Ask size) | - |
| Open | 2.075 EUR |
| High | 2.075 EUR |
| Low | 2.075 EUR |
| Close (prev. day) | 2.075 EUR |
| VWAP | 2.15 EUR |
| Volume (pcs) | 0 |
| Trading volume | 0.00 |
| Number of trades | 1 |
| Last size | 0 |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | -11.51% | -22.28% | - |
| Perf (abs.) | -0.27 | -0.60 | - |
| Beta | 0.98 | 0.93 | 0.95 |
| Volatility | 23.94 | 32.29 | - |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 2.063 EUR (0) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 2.050 EUR (0) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 2.193 EUR (0) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 2.320 EUR (1) |
| YTD High | date | 2.695 EUR (2024/01/05) |
| YTD Low | date | 1.930 EUR (2024/07/01) |
| 52 Weeks High | date | 2.955 EUR (2023/09/05) |
| 52 Weeks Low | date | 1.930 EUR (2024/07/01) |
All listings for INNATE PHARMA SA
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Tradegate | 2024/08/30 | 22:26 | 2.095 EUR | 0.00 | 1 |
| Stuttgart | 2024/08/30 | 15:42 | 2.065 EUR | 0.00 | 5 |
| Munich | 2024/08/30 | 08:20 | 2.075 EUR | 0.00 | 1 |
| London Stock Exchange European Trade Reporting | 2024/08/30 | 17:30 | 2.1075 EUR | 0.00 | 2 |
| Frankfurt | 2024/08/30 | 08:10 | 2.07 EUR | 0.00 | 2 |
| FINRA other OTC Issues | 2024/08/22 | 19:37 | 2.30 USD | 0.00 | 1 |
| Euronext Paris | 2024/08/30 | 17:35 | 2.09 EUR | 0.08 | 141 |
| Duesseldorf | 2024/08/30 | 08:11 | 2.085 EUR | 0.00 | 3 |
| Berlin | 2024/08/30 | 08:20 | 2.07 EUR | 0.00 | 3 |
Company Profile
| - |
Board of directors
| Irina Staatz-Granzer | Chairman of Supervisory Board |
| Jean-Yves Blay | Member of Supervisory Board |
| Olivier Martinez | Member of Supervisory Board |
| Sally Bennett | Member of Supervisory Board |
| Véronique Chabernaud | Member of Supervisory Board |
| Gilles Brisson | Member of Supervisory Board |
| Pascale Boissel | Member of Supervisory Board |